[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fyRHcnVLAJEEeKn6qvajUq7pGGkWM3_aoJB8bC_MVt2U":8,"$fu1xd8eWEJQe9mt1xo2DeTWVvog5cJi_P05voJg-71Nw":61,"$fumHPjKhZBSBl-PIGXSWnM2QGINfoGvrTP0T-lNUJU_M":62,"$fNmm5uOCPyekJWFoXmSa7gdcr7l0rc6j-elzlyGV4CuE":66},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":60},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"roleType":17,"adept":18,"hospital":19,"department":20,"postsTitle":21,"materialTotal":17,"videoTotal":22,"isConcern":7,"title":23,"coverVertical":24,"coverAcross":25,"directionMarker":26,"description":27,"vid":28,"time":29,"mediaType":30,"views":31,"likes":17,"isThumbsUp":7,"isCollection":7,"collections":17,"createTime":32,"seoTitle":33,"seoKeywords":34,"seoDescription":35,"shelvesTime":36,"menus":37,"menuId":39,"type":26,"quality":57,"commentCount":17,"isComment":30,"deviceType":58,"url":59},7231,863558,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//32vpB2YdXqGTJoHAb5XMTQr7lVbwC1dd.png","邓立松",0,"擅长糖尿病、高血压、冠心病、急慢性心衰等疾病诊疗","青岛市南泗水路社区卫生服务站","全科医疗","主治医师",6,"高血压并发症风险翻倍？银杏叶提提物阿托伐他汀联合用药的3大临床突破！","https://cdn.yishi-tong.com/console/3/AqNZDBmssYOJj7tc_o2egMianA2M2sJt.png","https://cdn.yishi-tong.com/console/3/jGefLuWQ9CFeRUyBA0FwvZDPRYT-pUdO.png",2,"高血压并发症风险翻倍？银杏叶提提物阿托伐他汀联合用药的3大临床突破！\n大家好，今天我们来聊聊高血压及其并发症，特别是针对一位85岁女性患者的案例。\n这位患者已经罹患高血压超过20年，日常服用降压药控制血压。然而，最近她出现了头晕和耳鸣等不适，经过检查，最高血压为150/90 mmHg，虽然心肺功能良好，但她的高血压控制并不理想。\n高血压并发症的风险是我们必须重视的问题。长期高血压可能导致心脏病、中风、肾脏损害等严重后果。对于这位患者来说，虽然她的日常用药能够在一定程度上控制血压，但并发症的出现提示我们需要重新评估她的治疗方案。\n在这种情况下，银杏叶提取物的联合用药可能会带来新的希望。具有以下三大临床突破：\n\n\n多重作用机制：银杏叶提取物不仅能改善血管内皮功能，减少心血管事件的发生风险。这对于长期高血压患者尤为重要。\n\n\n良好的耐受性：银杏叶提取物副作用相对较少，患者在使用过程中更容易坚持用药，从而提高治疗的依从性。\n\n\n个体化治疗：银杏叶提取物可以根据患者的具体情况进行剂量调整，适合不同年龄段和健康状况的患者，尤其是老年患者。\n在日常生活中，患者还需保持健康的饮食习惯，低盐、低脂、低糖，定期监测血压，并进行适量运动，调节情绪，保持充足睡眠。定期复诊和随访也是非常重要的，尤其是在出现不适时，及时与医生沟通。\n总之，高血压及其并发症是一个复杂的问题，需要综合考虑药物治疗和生活方式的调整。希望通过今天的分享，大家能对高血压有更深入的了解，关注自身健康。\n","v0247cg10004d2v88lqljhtaphm673d0",242,1,565,"2025-06-19 14:37:47","高血压并发症风险翻倍？银杏叶提取物联合阿托伐他汀的3大临床突破  \n","高血压并发症，银杏叶提取物，阿托伐他汀，联合用药，临床突破，心血管风险  \n","最新研究发现，高血压患者并发症风险可能翻倍！银杏叶提取物与阿托伐他汀联合用药带来3大临床突破：显著降低心血管事件、改善血管功能、减少药物副作用。了解这一创新疗法如何帮助高血压患者更好控制病情。","2025-06-25 17:20:00",[38],{"menuId":39,"menuName":40,"parentId":17,"orderNum":41,"path":42,"component":43,"isFrame":44,"isCache":45,"menuType":46,"visible":30,"status":17,"createDept":6,"remark":47,"createTime":48,"children":49,"columnImage":50,"columnLogo":51,"uncheckedLogo":6,"checkedLogo":6,"isHot":17,"isHome":17,"forceLogin":17,"color":6,"seoTitle":52,"seoKeywords":53,"seoDescription":54,"contentNum":6,"promotionalPoster":55,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":56,"routerPath":42,"componentInfo":43},"1986622624134549505","科普视频",3,"video","/video.html","1","0","T","","2025-11-07 10:31:58",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:40/0d7fcb56-3dc4-4dcb-99ca-a5d5c438378e.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:43/958efac7-dd02-4681-b8fd-0dd84b1bbf42.png","健康科普视频大全,了解你的健康生活","健康科普视频, 戒烟视频, 饮食健康视频, 胸痛科普, 用药知识, 职业健康视频, 贫血科普, 眼健康视频","精选健康科普视频,涵盖戒烟、胸痛、饮食、用药与职业健康等多个主题,让你轻松获取科学健康知识,提升生活质量。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:45/fa8fe113-deaa-4454-8105-d629769963dd.png","Video","慢性病",4,"https://vod.haohuanjiao.com/huanjiao/specialistVideo/863558/6c5ede92-4ea0-4e90-9386-eb5e264c7751.tmp?a=0&auth_key=1789064691-699d3dca6ffd45c88b8a799789ba805e-0-2494b8ea77430b92cc54bdf0b629de41&br=851&bt=851&cd=0%7C0%7C0&ch=0&cr=0&cs=0&dr=0&ds=3&eid=v0247cg10004d2v88lqljhtaphm673d0&er=0&l=202608111620441B989C2194AC05C7A6DB&lr=&mime_type=video_mp4&net=0&pl=0&qs=13&rc=MzY5a2Rrb287NTczNGY3M0ApZzpwc3dtdDt5ZzMzajo1eWdhNGptcWduNXNhLS1kNC9zcy0wM2VeZWlpNS8xLS5gMS06Yw%3D%3D&vl=&vr=",true,{"code":9,"msg":59,"message":6,"data":6,"success":60},{"code":9,"msg":10,"message":6,"data":63,"success":60},{"pageNo":30,"pageSize":64,"result":65,"totalSize":17},10,[],{"code":9,"msg":10,"message":6,"data":67,"success":60},{"authors":68,"appraiseDimensionScoresVos":69},[],[]]